However, in our subgroup analysis, continuing RASi was associated with favorable outcomes even in patients with low urine protein, one of the features of atherosclerotic nephrocalcinosis, suggesting that age-related atherosclerosis does not fully explain the age-related differences. Here, MMP19 is linked to atherosclerosis.